ResMed Files Another Request for Import Ban on Patent-Infringing Breathing Treatment Devices

ResMed filed another Section 337 complaint on sleep-disordered breathing treatment devices with the International Trade Commission on July 19, alleging imports by BMC Medical of China and its U.S. affiliates 3B Medical and 3B Products, are infringing its patents. The ITC began another Section 337 investigation requested by ResMed in April, that time over allegations against a Taiwan-based company (see 13042914). The products at issue are used in the treatment of obstructive sleep apnea by delivering pressurized air to the user to keep that user’s breathing passages open during sleep, the petition said. ResMed is requesting limited exclusion orders and cease and desist orders against the proposed respondents.